These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6696524)

  • 41. Methotrexate treatment of rheumatoid arthritis: effects on radiological progression.
    Reykdal S; Steinsson K; Sigurjónsson K; Brekkan A
    Scand J Rheumatol; 1989; 18(4):221-6. PubMed ID: 2799303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A radiologic method of assessment of bone and joint destruction in rheumatoid arthritis.
    Bluhm GB; Smith DW; Mikulashek WM
    Henry Ford Hosp Med J; 1983; 31(3):152-61. PubMed ID: 6643095
    [No Abstract]   [Full Text] [Related]  

  • 43. Radiological changes in rheumatoid arthritis: measurement of area of juxta-articular bone as outcome event in clinical therapeutic trials of antirheumatic drugs.
    Buchanan HM; Buchanan WW; Cockshott WP; Kamath MV; Ghista DN
    Clin Rheumatol; 1988 Dec; 7(4):481-5. PubMed ID: 3073035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum matrix metalloproteinase 3 in early rheumatoid arthritis is correlated with disease activity and radiological progression.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    J Rheumatol; 2000 Dec; 27(12):2761-8. PubMed ID: 11128661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study.
    Plant MJ; Jones PW; Saklatvala J; Ollier WE; Dawes PT
    J Rheumatol; 1998 Mar; 25(3):417-26. PubMed ID: 9517757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can 'disease modifying' drugs influence outcome in rheumatoid arthritis?
    Situnayake RD
    Br J Rheumatol; 1988; 27 Suppl 1():55-65. PubMed ID: 3277686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease.
    van Leeuwen MA; van Rijswijk MH; van der Heijde DM; Te Meerman GJ; van Riel PL; Houtman PM; van De Putte LB; Limburg PC
    Br J Rheumatol; 1993 Jun; 32 Suppl 3():9-13. PubMed ID: 8508266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group.
    Kirwan JR
    N Engl J Med; 1995 Jul; 333(3):142-6. PubMed ID: 7791815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis. Clinical benefits and skeletal side effects.
    Hansen M; Podenphant J; Florescu A; Stoltenberg M; Borch A; Kluger E; Sørensen SF; Hansen TM
    Ann Rheum Dis; 1999 Nov; 58(11):713-8. PubMed ID: 10531077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiologically observed progression of joint destruction and its relationship with demographic factors, disease severity, and exercise frequency in patients with rheumatoid arthritis.
    Stenström CH
    Phys Ther; 1994 Jan; 74(1):32-9. PubMed ID: 8265726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.
    Amos RS; Constable TJ; Crockson RA; Crockson AP; McConkey B
    Br Med J; 1977 Jan; 1(6055):195-7. PubMed ID: 832072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of age on 3 year outcome in early rheumatoid arthritis.
    Peltomaa R; Leirisalo-Repo M; Helve T; Paimela L
    J Rheumatol; 2000 Mar; 27(3):638-43. PubMed ID: 10743801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased metacarpal bone mass following 18 months of slow-acting antirheumatic drugs for rheumatoid arthritis.
    Kalla AA; Meyers OL; Chalton D; Heath S; Brown GM; Smith PR; Burger MC
    Br J Rheumatol; 1991 Apr; 30(2):91-100. PubMed ID: 2012963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic laboratory markers of joint damage in rheumatoid arthritis.
    Lindqvist E; Eberhardt K; Bendtzen K; Heinegård D; Saxne T
    Ann Rheum Dis; 2005 Feb; 64(2):196-201. PubMed ID: 15458956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term efficacy of leflunomide on disease activity and inhibition of joint damage: retrospective comparison with methotrexate for Japanese rheumatoid arthritis patients.
    Katayama K; Matsuno T
    Mod Rheumatol; 2009; 19(5):513-21. PubMed ID: 19603251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disease activity and joint damage progression in early rheumatoid arthritis: relation to IgG, IgA, and IgM rheumatoid factor.
    Eberhardt KB; Truedsson L; Pettersson H; Svensson B; Stigsson L; Eberhardt JL; Wollheim FA
    Ann Rheum Dis; 1990 Nov; 49(11):906-9. PubMed ID: 2256736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiological damage in patients with rheumatoid arthritis on sustained remission.
    Cohen G; Gossec L; Dougados M; Cantagrel A; Goupille P; Daures JP; Rincheval N; Combe B
    Ann Rheum Dis; 2007 Mar; 66(3):358-63. PubMed ID: 16935911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Changes of bone mineral density in rheumatoid arthritis].
    Savickiene A; Baranauskaite A
    Medicina (Kaunas); 2003; 39(5):464-8. PubMed ID: 12794369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease.
    Machold KP; Stamm TA; Nell VP; Pflugbeil S; Aletaha D; Steiner G; Uffmann M; Smolen JS
    Rheumatology (Oxford); 2007 Feb; 46(2):342-9. PubMed ID: 16899498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis.
    Hammer HB; Odegard S; Fagerhol MK; Landewé R; van der Heijde D; Uhlig T; Mowinckel P; Kvien TK
    Ann Rheum Dis; 2007 Aug; 66(8):1093-7. PubMed ID: 17234650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.